BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mougari F, Guglielmetti L, Raskine L, Sermet-Gaudelus I, Veziris N, Cambau E. Infections caused by Mycobacterium abscessus: epidemiology, diagnostic tools and treatment. Expert Rev Anti Infect Ther 2016;14:1139-54. [PMID: 27690688 DOI: 10.1080/14787210.2016.1238304] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 6.2] [Reference Citation Analysis]
Number Citing Articles
1 Jansson PS, Wright KN, Goldberg SA, Easter SR, Wilcox SR, Wittels KA. A Woman With a Surgical Site Infection. J Emerg Med 2022;62:429-36. [PMID: 35063318 DOI: 10.1016/j.jemermed.2021.10.036] [Reference Citation Analysis]
2 Anversa Dimer F, de Souza Carvalho-Wodarz C, Goes A, Cirnski K, Herrmann J, Schmitt V, Pätzold L, Abed N, De Rossi C, Bischoff M, Couvreur P, Müller R, Lehr CM. PLGA nanocapsules improve the delivery of clarithromycin to kill intracellular Staphylococcus aureus and Mycobacterium abscessus. Nanomedicine 2020;24:102125. [PMID: 31751769 DOI: 10.1016/j.nano.2019.102125] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
3 Jhun BW, Yang B, Moon SM, Lee H, Park HY, Jeon K, Kwon OJ, Ahn J, Moon IJ, Shin SJ, Daley CL, Koh WJ. Amikacin Inhalation as Salvage Therapy for Refractory Nontuberculous Mycobacterial Lung Disease. Antimicrob Agents Chemother 2018;62:e00011-18. [PMID: 29661870 DOI: 10.1128/AAC.00011-18] [Cited by in Crossref: 29] [Cited by in F6Publishing: 12] [Article Influence: 7.3] [Reference Citation Analysis]
4 Yue C, Wang L, Wang X, Cen R, Chen J, Li L, Yang W, Tan Y, Lei X. In vitro study of the effect of ALA-PDT on Mycobacterium abscessus and its antibiotic susceptibility. Photodiagnosis Photodyn Ther 2022;:102802. [PMID: 35297368 DOI: 10.1016/j.pdpdt.2022.102802] [Reference Citation Analysis]
5 Viljoen A, Herrmann JL, Onajole OK, Stec J, Kozikowski AP, Kremer L. Controlling Extra- and Intramacrophagic Mycobacterium abscessus by Targeting Mycolic Acid Transport. Front Cell Infect Microbiol 2017;7:388. [PMID: 28920054 DOI: 10.3389/fcimb.2017.00388] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
6 Degiacomi G, Sammartino JC, Chiarelli LR, Riabova O, Makarov V, Pasca MR. Mycobacterium abscessus, an Emerging and Worrisome Pathogen among Cystic Fibrosis Patients. Int J Mol Sci 2019;20:E5868. [PMID: 31766758 DOI: 10.3390/ijms20235868] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 6.3] [Reference Citation Analysis]
7 Jones RS, Shier KL, Master RN, Bao JR, Clark RB. Current significance of the Mycobacterium chelonae-abscessus group. Diagn Microbiol Infect Dis 2019;94:248-54. [PMID: 30954313 DOI: 10.1016/j.diagmicrobio.2019.01.021] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
8 Tiong CW, Nack T, Tai AYC, Friedman ND. Medical management of atraumatic Mycobacterium abscessus cutaneous infection: A case report. J Clin Tuberc Other Mycobact Dis 2019;17:100132. [PMID: 31867443 DOI: 10.1016/j.jctube.2019.100132] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
9 Chen S, Teng T, Zhang Z, Shang Y, Xiao H, Jiang G, Wang F, Jia J, Dong L, Zhao L, Chu N, Huang H. Carbonyl Cyanide 3-Chlorophenylhydrazone (CCCP) Exhibits Direct Antibacterial Activity Against Mycobacterium abscessus. Infect Drug Resist 2021;14:1199-208. [PMID: 33790590 DOI: 10.2147/IDR.S303113] [Reference Citation Analysis]
10 Summers NA, Kempker R, Palacio F. Mycobacterium abscessus subspecies massiliense infection after skin graft and cholecystectomy in a burn patient. Int J Infect Dis 2018;76:29-31. [PMID: 30170154 DOI: 10.1016/j.ijid.2018.08.016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Kaushik A, Ammerman NC, Lee J, Martins O, Kreiswirth BN, Lamichhane G, Parrish NM, Nuermberger EL. In Vitro Activity of the New β-Lactamase Inhibitors Relebactam and Vaborbactam in Combination with β-Lactams against Mycobacterium abscessus Complex Clinical Isolates. Antimicrob Agents Chemother 2019;63:e02623-18. [PMID: 30642943 DOI: 10.1128/AAC.02623-18] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 8.3] [Reference Citation Analysis]
12 Carter KK, Lundgren I, Correll S, Schmalz T, McCarter T, Stroud J, Bruesch A, Hahn CG. First United States Outbreak of Mycobacterium abscessus Hand and Foot Disease Among Children Associated With a Wading Pool. J Pediatric Infect Dis Soc 2019;8:291-6. [PMID: 29850835 DOI: 10.1093/jpids/piy036] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
13 Chew KL, Octavia S, Go J, Ng S, Tang YE, Soh P, Yong J, Jureen R, Lin RTP, Yeoh SF, Teo J. In vitro susceptibility of Mycobacterium abscessus complex and feasibility of standardizing treatment regimens. J Antimicrob Chemother 2021;76:973-8. [PMID: 33338230 DOI: 10.1093/jac/dkaa520] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
14 Mickymaray S, Alfaiz FA, Paramasivam A. Efficacy and Mechanisms of Flavonoids against the Emerging Opportunistic Nontuberculous Mycobacteria. Antibiotics (Basel) 2020;9:E450. [PMID: 32726972 DOI: 10.3390/antibiotics9080450] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Chew KL, Octavia S, Jureen R, Ng OT, Marimuthu K, Lin RTP, Teo JWP. Molecular epidemiology and phylogenomic analysis of Mycobacterium abscessus clinical isolates in an Asian population. Microb Genom 2021;7. [PMID: 34845980 DOI: 10.1099/mgen.0.000708] [Reference Citation Analysis]
16 Pang Y, Lu J, Su B, Zheng H, Zhao Y. Misdiagnosis of tuberculosis associated with some species of nontuberculous mycobacteria by GeneXpert MTB/RIF assay. Infection 2017;45:677-81. [PMID: 28707184 DOI: 10.1007/s15010-017-1044-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
17 Kim HJ, Kim IS, Lee SG, Kim YJ, Silwal P, Kim JY, Kim JK, Seo W, Chung C, Cho HK, Huh HJ, Shim SC, Park C, Jhun BW, Jo EK. MiR-144-3p is associated with pathological inflammation in patients infected with Mycobacteroides abscessus. Exp Mol Med 2021;53:136-49. [PMID: 33473145 DOI: 10.1038/s12276-020-00552-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Egorova A, Jackson M, Gavrilyuk V, Makarov V. Pipeline of anti-Mycobacterium abscessus small molecules: Repurposable drugs and promising novel chemical entities. Med Res Rev 2021;41:2350-87. [PMID: 33645845 DOI: 10.1002/med.21798] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
19 Lopeman RC, Harrison J, Rathbone DL, Desai M, Lambert PA, Cox JAG. Effect of Amoxicillin in combination with Imipenem-Relebactam against Mycobacterium abscessus. Sci Rep 2020;10:928. [PMID: 31988293 DOI: 10.1038/s41598-020-57844-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
20 Grzegorzewicz A, Paściak M. The key factors contributing to the risk, diagnosis and treatment of non-tuberculous mycobacterial opportunistic infections. Postępy Higieny i Medycyny Doświadczalnej 2021;75:696-710. [DOI: 10.2478/ahem-2021-0050] [Reference Citation Analysis]
21 Abukhalid N, Islam S, Ndzeidze R, Bermudez LE. Mycobacterium avium Subsp. hominissuis Interactions with Macrophage Killing Mechanisms. Pathogens 2021;10:1365. [PMID: 34832521 DOI: 10.3390/pathogens10111365] [Reference Citation Analysis]
22 Compain F, Soroka D, Heym B, Gaillard JL, Herrmann JL, Dorchène D, Arthur M, Dubée V. In vitro activity of tedizolid against the Mycobacterium abscessus complex. Diagn Microbiol Infect Dis 2018;90:186-9. [PMID: 29217419 DOI: 10.1016/j.diagmicrobio.2017.11.001] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
23 Cavalier JF, Spilling CD, Durand T, Camoin L, Canaan S. Lipolytic enzymes inhibitors: A new way for antibacterial drugs discovery. Eur J Med Chem 2021;209:112908. [PMID: 33071055 DOI: 10.1016/j.ejmech.2020.112908] [Reference Citation Analysis]
24 Le Moigne V, Bernut A, Cortès M, Viljoen A, Dupont C, Pawlik A, Gaillard JL, Misguich F, Crémazy F, Kremer L, Herrmann JL. Lsr2 Is an Important Determinant of Intracellular Growth and Virulence in Mycobacterium abscessus. Front Microbiol 2019;10:905. [PMID: 31114557 DOI: 10.3389/fmicb.2019.00905] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
25 Richard M, Gutiérrez AV, Viljoen AJ, Ghigo E, Blaise M, Kremer L. Mechanistic and Structural Insights Into the Unique TetR-Dependent Regulation of a Drug Efflux Pump in Mycobacterium abscessus. Front Microbiol 2018;9:649. [PMID: 29675007 DOI: 10.3389/fmicb.2018.00649] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
26 Vianna JS, Machado D, Ramis IB, Silva FP, Bierhals DV, Abril MA, von Groll A, Ramos DF, Lourenço MCS, Viveiros M, da Silva PEA. The Contribution of Efflux Pumps in Mycobacterium abscessus Complex Resistance to Clarithromycin. Antibiotics (Basel) 2019;8:E153. [PMID: 31540480 DOI: 10.3390/antibiotics8030153] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
27 Quang NT, Jang J. Current Molecular Therapeutic Agents and Drug Candidates for Mycobacterium abscessus. Front Pharmacol 2021;12:724725. [PMID: 34526902 DOI: 10.3389/fphar.2021.724725] [Reference Citation Analysis]
28 Tortoli E, Kohl TA, Trovato A, Baldan R, Campana S, Cariani L, Colombo C, Costa D, Cristadoro S, Di Serio MC, Manca A, Pizzamiglio G, Rancoita PM, Rossolini GM, Taccetti G, Teri A, Niemann S, Cirillo DM. Mycobacterium abscessus in patients with cystic fibrosis: low impact of inter-human transmission in Italy. Eur Respir J 2017;50:1602525. [DOI: 10.1183/13993003.02525-2016] [Cited by in Crossref: 30] [Cited by in F6Publishing: 21] [Article Influence: 6.0] [Reference Citation Analysis]
29 Shen Y, Wang X, Jin J, Wu J, Zhang X, Chen J, Zhang W. In Vitro Susceptibility of Mycobacterium abscessus and Mycobacterium fortuitum Isolates to 30 Antibiotics. Biomed Res Int 2018;2018:4902941. [PMID: 30687747 DOI: 10.1155/2018/4902941] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
30 Zhukhovitskaya A, Chang DT, Huoh KC, Pham NS, Singh J, Ahuja GS. Surgical management of atypical mycobacterial cervical lymphadenitis in an outbreak of odontological infection. Int J Pediatr Otorhinolaryngol 2020;131:109882. [PMID: 31981916 DOI: 10.1016/j.ijporl.2020.109882] [Reference Citation Analysis]
31 Shield CG, Swift BMC, McHugh TD, Dedrick RM, Hatfull GF, Satta G. Application of Bacteriophages for Mycobacterial Infections, from Diagnosis to Treatment. Microorganisms 2021;9:2366. [PMID: 34835491 DOI: 10.3390/microorganisms9112366] [Reference Citation Analysis]
32 Xie D, Xian Y, You J, Xu W, Fan M, Bi X, Zhang K. Co-Infection Pneumonia with Mycobacterium abscessus and Pneumocystis jiroveci in a Patient without HIV Infection Diagnosed by Metagenomic Next-Generation Sequencing. Infect Drug Resist 2021;14:879-88. [PMID: 33692629 DOI: 10.2147/IDR.S292768] [Reference Citation Analysis]
33 Gupta N, Banerjee S, Timitrov, Sharma R, Roy SG, Shende TM, Ansari MT, Singh G, Nischal N, Wig N, Soneja M. Osteomyelitis due to multiple rare infections in a patient with idiopathic CD4 lymphocytopenia. Intractable Rare Dis Res 2017;6:206-10. [PMID: 28944144 DOI: 10.5582/irdr.2017.01029] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
34 Guterres KB, Rossi GG, de Campos MMKA, Moreira KS, Burgo TAL, Iglesias BA. Metal center ion effects on photoinactivating rapidly growing mycobacteria using water-soluble tetra-cationic porphyrins. Biometals 2020;33:269-82. [PMID: 32980947 DOI: 10.1007/s10534-020-00251-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
35 Franco-Paredes C, Marcos LA, Henao-Martínez AF, Rodríguez-Morales AJ, Villamil-Gómez WE, Gotuzzo E, Bonifaz A. Cutaneous Mycobacterial Infections. Clin Microbiol Rev 2018;32:e00069-18. [PMID: 30429139 DOI: 10.1128/CMR.00069-18] [Cited by in Crossref: 44] [Cited by in F6Publishing: 16] [Article Influence: 11.0] [Reference Citation Analysis]
36 Diella G, Caggiano G, Triggiano F, Lopuzzo M, Apollonio F, Mastria M, Ronga L, Bonadonna L, Lucentini L, Pece A, Milella P, Montagna MT. An Artefactual Cluster of Mycobacterium abscessus Pneumonia among Cancer Patients Arising from Contamination. Pathogens 2022;11:108. [DOI: 10.3390/pathogens11010108] [Reference Citation Analysis]
37 Giovannenze F, Stifano V, Scoppettuolo G, Damiano F, Pallavicini F, Delogu G, Palucci I, Rapisarda A, Sturdà C, Pompucci A. Incidental intraoperative diagnosis of Mycobacterium abscessus meningeal infection: a case report and review of the literature. Infection 2018;46:591-7. [PMID: 29687315 DOI: 10.1007/s15010-018-1141-5] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
38 Chaton CT, Rodriguez ES, Reed RW, Li J, Kenner CW, Korotkov KV. Structural analysis of mycobacterial homoserine transacetylases central to methionine biosynthesis reveals druggable active site. Sci Rep 2019;9:20267. [PMID: 31889085 DOI: 10.1038/s41598-019-56722-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
39 Maslivetc VA, Turner DN, McNair KN, Frolova L, Rogelj S, Maslivetc AA, Aksenov NA, Rubina M, Rubin M. Desymmetrization of Cyclopropenes via the Potassium-Templated Diastereoselective 7- exo- trig Cycloaddition of Tethered Amino Alcohols toward Enantiopure Cyclopropane-Fused Oxazepanones with Antimycobacterial Activity. J Org Chem 2018;83:5650-64. [PMID: 29696970 DOI: 10.1021/acs.joc.8b00640] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
40 Smibert OC, Paraskeva MA, Westall G, Snell G. An Update in Antimicrobial Therapies and Infection Prevention in Pediatric Lung Transplant Recipients. Paediatr Drugs 2018;20:539-53. [PMID: 30187362 DOI: 10.1007/s40272-018-0313-1] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
41 Franco-Paredes C, Chastain DB, Allen L, Henao-Martínez AF. Overview of Cutaneous Mycobacterial Infections. Curr Trop Med Rep 2018;5:228-32. [PMID: 34164254 DOI: 10.1007/s40475-018-0161-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
42 Hohl M, Remm S, Eskandarian HA, Dal Molin M, Arnold FM, Hürlimann LM, Krügel A, Fantner GE, Sander P, Seeger MA. Increased drug permeability of a stiffened mycobacterial outer membrane in cells lacking MFS transporter Rv1410 and lipoprotein LprG. Mol Microbiol 2019;111:1263-82. [PMID: 30742339 DOI: 10.1111/mmi.14220] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]